Clinical Trial: Evaluation of Miricorilant on Liver Fat in Patients With MASLD
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition:
Nonalcoholic Steatohepatitis (NASH)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open-Label Study Evaluating the Effect of Miricorilant on Hepatic Lipids in Patients With Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Brief Summary:
A Phase 1, Open-Label Study Evaluating the Effect of Miricorilant on Hepatic Lipids in Patients with Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Read more